The role of H in MV attachment was initially postulated from studies on infection inhibition with anti-H antibodies and rosetting of simian red blood cells with H-expressing cells (reviewed in Gerlier et al., 1995) . Later, H was suggested to interact directly with CD46. The efficient capture of wild-type virus H relied on expression of CD46 (Gerlier et al., 1994) . A soluble form of H spontaneously shed from wild-type Hexpressing cells (Malvoisin & Wild, 1994) and wild-type H protein (Nussbaum et al., 1995) could be co-immunoprecipitated with CD46. Finally, H from a crude extract of MV was able to bind to SDS-denatured CD46 (Maisner et al., 1994) . However, these experiments failed to prove formally that H can interact with CD46 in the absence of any virus or cellular cofactor, because either H was contaminated with F or CD46 with moesin. Moreover, the relevance of these findings to virus binding and entry was not directly tested.
Direct binding of H to CD46 was tested using purified recombinant soluble (s) ectodomains of CD46 and H. To engineer a soluble dimeric form of the type II transmembrane protein MV H, the cDNA encoding its ectodomain was fused in-flame behind the influenza virus haemagglutinin leader and Flag peptide sequences in the pTEJS.HA vector (D. Marguet, unpublished results) and transfected into P815 cells, sH Flag was partially purified by immunoaffinity with anti-Flag antibody. After SDS--PAGE under non-reducing conditions and silver staining, three bands with apparent molecular masses of 160, 74 and 67 kDa were detected in the purified fraction (Fig. la,  lane 1) . Under reducing conditions three bands with apparent molecular masses of 75, 68 and 60 kDa were detected ( Fig. 1 a,  lane 3) . The unreduced 160 kDa and reduced 68-75 kDa bands were identified by Western blotting as dimeric and monomeric sH Flag (Fig. la, lanes 2 and 4) . The other strong bands were identified as BSA. The sizes of dimeric and monomeric recombinant sH were consistent, with a reduction in size of about 12 and 6 kDa due to the lack of the cytoplasmic and transmembrane domains, respectively. The quantity of sH Flag secreted was low (1-3 pg per 106 cells per day); after metabolic radiolabelling, the sH Flag was expressed intracellularly at a high level but poorly secreted, indicating an inefficient maturation in the absence of a membrane anchor. The sH Flag was recognized in a dot-blot assay by MAbs 18c13, 19H40, 48c16, 50cll, 50H40, 85c16, 85H40, 87c11, 90H40, c115, c185, 47 . CD46 was identified using anti-CD46 J4,48 antibody (lanes 3 and 4) and moesin using anti-moesin 38/87 antibody (lanes 5-7). As a control, a ceil lysate equivatent to 2 x 105 HeLa ceils was aiso analysed by Western blotting for moesin (lane 7), SDS-PAGE (10% acrylamide) was performed under reducing (lane 1, 2, 5-7) and nonreducing (lanes 3 and 4) conditions. Apparent molecular massses are indicated. .,'4-/ / / 1 10 100 sCD46 (pg/ml) C155 and I29 anti-H, indicating a conformation close to that of wild-type transmembrane H. Recombinant soluble sCD46BCU-I, consisting of the four short consensus repeat (SCR) domains of CD46, STP-B and C, and the membrane proximal region (U), was produced and purified as described elsewhere (Christiansen el al., 1995) . Another source of sCD46 Bey (designated sCD46Bcu-II) was kindly provided by G. C. Yeh (CytoMed, Cambridge, Mass., USA; G. C. Yeh, Y.J. Wu, M. Brown, M. Krych, J. Ko, C. Sardonini, P. J. Higgins, T. J. Oglesby, J. P. Atkinson and S. H. Ip, unpublished results). After PAGE and silver staining, a single band with molecular mass of 60 kDa was detected in both sCD46Bcu-I and -II preparations, with no detectable contaminants (Fig. I b , lanes I and 2) even after overloading with purified recombinant proteins (data not shown). This band was identified as CD46 by Western blotting (Fig. lb, lanes 3  and 4) . Purified sCD46 preparations were found to be devoid of moesin (75 kDa) by Western blotting even after loading with up to 2"5 I~g protein (Fig. I b, lanes 5 and 6) , whereas the moesin content of only 2 x 105 HeLa cells could be readily visualized (Fig. I b, lane 7) .
Purified sCD46Bcu-II was immobilized by absorption onto plastic wells and sH Flag was tested for its ability to bind to CD46. sH binding was detected using H-specific MAb 19H40, which cannot inhibit haemagglutination (i.e. recognizes an epitope located outside the receptor-binding site). As shown in Fig. 2(a) , sH ~'lag from a crude supernatant bound to immobilized sCD46 and saturation occurred at 0"008 riM-ili ! ! ! iiiiii 6 @ii i 6 iiiiiii!i!i!iiiiiiiii¢iiiiiiiiiiiiiiiiiiiilj iiili sH Flag (1"2 I~g/ml). Furthermore, preincubation of sH Flag with purified sCD46Bcu-I or -II inhibited its binding onto the immobilized sCD46 (Fig. 2 b) , whereas only partial inhibition by sCD4 (Idziorek & Klatzmann, 1991) could be observed at high concentration. These data demonstrated that the recombinant soluble ectodomains of CD46 and H can directly interact in the absence of any other molecule including cellular moesin and virus F protein.
Can sH Flag interact with cell surface-expressed CD467 Its ability to agglutinate African green monkey erythrocytes which express the simian CD46 homologue (Gerlier et al., 1995) was tested. Haemagglutination was observed but only in the presence of 19H40 anti-H antibody and mouse anti-Ig antibodies; it was inhibited by another anti-H antibody which has a strong haemagglutination inhibitory activity. The lack of direct haemagglutinin activity of sH Flag indicated that the homodimers do not further associate into a higher polymeric structure. The direct binding of sH f~ag to cell surface CD46 was investigated. Rodent CHO cells not expressing CD46 (Fig. 3 a) and their transfected counterparts, CHO-CD46 cells (5.3 subline expressing the B-Cyt-2 CD46 isoform; Loveland et al., 1993; Fig. 3 c) were incubated in the presence or absence of crude sH Flag and the binding was assessed by flow immunocytometry, sH binding was detected on cells expressing CD46 (Fig. 3d) but not on parental CHO cells (Fig. 3b) . The sH binding to CHO-CD46 cells was proportional to the amount of soluble protein added, saturation being reached at 0"02 nM (3"5 gg/ml) i.e. within the same range as the saturating concentration for binding to sCD46 immobilized on plastic.
Can sCD46 interact with wild-type cell surface MV H? Mouse L.HA cells, expressing MV H (Fig. 3g) , bound purified sCD46Bcu-I as detected by flow immunocytometry (Fig. 3 h) , whereas parental L cells which lacked surface H (Fig. 3 e) did not bind sCD46 (Fig. 3J) . The sCD46 binding was proportional to the amount of soluble protein added, saturation being observed at 5 nM (300 lag/ml) of sCD46 i.e. about 250 times higher than the concentration of sH needed to saturate cell surface CD46. The reason for this discrepancy is unknown. It could be due to the homodimeric form of sH and monomeric form of sCD46 and/or to a partial denaturation of the purified sCD46. When sCD46 (50 lag/ml) was incubated with cells coexpressing H and F after infection with recombinant vaccinia virus encoding both proteins, the amount of bound sCD46 was almost twofold (mean of 10 experiments 1"9 4-0"3) higher than when ceils expressed the same amount of cell surface H (as determined by immunocytometry). No binding of sCD46 was detected on L cells expressing F alone.
Is the direct interaction between CD46 and H relevant in virus binding? Pre-incubation of 2 x 105 CHO-CD46 cells with a saturating concentration of crude sH Flag (7 lag/ml, 30 min, 4 °C) inhibited their ability to bind MV by 60% when incubated with 6"5 lag of purified virus for I h at 4 °C (Naniche et al., 1993) , whereas a control supematant had no effect. Preincubation of MV with a subsaturating concentration (50 ~tg/ml) of sCD46BeU-I and sCD46Bcu-II resulted in 34% and 60% inhibition, respectively; sCD4 had no inhibitory effect. A lower amount of sCD46 resulted in a lower inhibition of MV binding. Thus, the recombinant soluble forms of H and CD46 can compete for CD46-mediated MV binding.
When sCD46 was used to inhibit H + F-mediated fusion of 2 x 104 human HeLa cells infected with recombinant vaccinia virus encoding H and F (0"2 p.f.u./cell overnight), it surprisingly had no inhibitory effect at 50 ~tg/ml. When added to 5 x i05 HeLa cells infected with 300 p.f.u, of MV, sCD46 weakly inhibited infection (about 35 % inhibition after 4 days of culture with 50 lag/ml of sCD46), in agreement with a recent report using another recombinant soluble form (sCD46C; Seya et al., 1995) . A complete inhibition was observed when 15000 HeLa cells were infected with 1500 p.f.u, in the presence of 50 ~tg/ml of purified sCD46 BeU-I or sCD46Be~-II for I h at 3 7 °C, followed by two washes in 50 ml medium, and layered on a Veto cell monolayer (infection focus assay). But, decreasing sCD46 concentration resulted in a rapid loss of inhibition of infection, confirming that sCD46 was much less potent than known specific inhibitors of MVinduced fusion and infection such as anti-H MAb c155 (Giraudon & Wild, 1985) or anti-CD46 MCI.20.6 antibody (Naniche et aI., 1992) . This poor efficiency of sCD46 may be related to its monomeric form. Interestingly, a multimeric seminal prostasome form of CD46 displayed a stronger inhibitory effect on MV infection (Kitamura et al., 1995) .
These results agree with the postulated role of MV H and CD46 in MV attachment to its natural human target cells. To our knowledge, there is no evidence for any role of F protein in virus-cell binding. Although F protein is not required for H binding to CD46, it does influence the strength of this binding. Is it due to some secondary interaction of CD46 with F or to a conformational change in H when complexed to F? Interestingly, H but not F could be co-immunoprecipitated with CD46 (Nussbaum et al., 1995) , A major contribution for moesin in CD46-mediated MV binding is unlikely because purified sCD46, without evidence of a 75 kDa contaminant moesin-sized protein, bound efficiently to both MV H and MV. Moreover, sH did not bind to parental CHO cells although they can be labelled with anti-moesin 38/87 antibodies (data not shown). Accordingly, MV glycoproteins could not bind to moesin (Maisner el al., 1994) . We thus favour the hypothesis that, in CD46-mediated MV infection, moesin may play a role only in a post-binding event,
The MV binding site mapped to the SCR1 and two domains of CD46 (Iwata et al., 1995; Manchester eta] ., 1995 ; Buchholz et al., 1996) . Whether the binding site of sH on CD46 is similar to that of the virus is currently under investigation.
